会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明授权
    • P2Y4 antibodies
    • P2Y4抗体
    • US07312317B2
    • 2007-12-25
    • US10811198
    • 2004-03-26
    • Didier CommuniJean-Marie BoeynaemsMarc ParmentierSabine Pirotton
    • Didier CommuniJean-Marie BoeynaemsMarc ParmentierSabine Pirotton
    • C07K16/18A61K39/395
    • C07K14/705A01K2217/05A01K2217/075C12N2310/14
    • This invention provides a receptor having a preference for pyrimidine nucleotides preferably uridine triphosphate over purine nucleotides. A receptor having a preference for pyrimidine nucleotides over purine nucleotides means a receptor for which pyrimidine nucleotides and purine nucleotides are not equally active and equipotent. This means that the receptor according to the invention in presence of these agonists presents a functional response (preferably the accumulation of Inositol triphosphate (IP3), diacylglycerol (DAG), or calcium ions) to lower concentration of pyrimidine nucleotides, preferably uridine triphosphate, than to purine nucleotides or a more important functional response to similar concentration of pyrimidine nucleotide than to purine nucleotide.
    • 本发明提供了对嘌呤核苷酸优先选择嘧啶核苷酸优选尿苷三磷酸的受体。 对嘌呤核苷酸优先选择嘧啶核苷酸的受体是指嘧啶核苷酸和嘌呤核苷酸不具有同等活性和等同性的受体。 这意味着在这些激动剂存在下,根据本发明的受体具有功能性反应(优选三聚磷酸肌醇(IP3),二酰基甘油(DAG)或钙离子)的积累)以降低嘧啶核苷酸浓度,优选尿苷三磷酸 嘌呤核苷酸或与嘌呤核苷酸相似浓度的嘧啶核苷酸的更重要的功能反应。